GENORAY Ranks No. 1 in Domestic Market Share Across Three Sectors, Including C-arm and Mammography

Medical imaging equipment company GENORAY (CEO Park Byung-wook) announced on the 14th that, according to its 2025 fiscal year-end results, it has achieved the number one cumulative domestic market share in three key product categories: C-arm (mobile X-ray fluoroscopy system), Mammography, and ENT (ENT CT). The company explained that this achievement is significant as it reflects the clinical trust and reliable maintenance established within the medical device market.

GENORAY stated that it maintains an export-oriented structure, with over 75% of its total revenue generated overseas, while the domestic market serves as a foundation for technical validation and the accumulation of product operational experience.

The company provides equipment maintenance and customer support services through five regional offices across the country, which it noted is key to ensuring the operational stability of its products.

Success in the global market is also becoming increasingly visible. Recently, GENORAY signed a mobile C-arm ODM supply agreement with the Japanese precision instrument company SHIMADZU Corporation. Furthermore, the company is expanding its supply chain in key strategic countries, including Brazil and Russia, following the selection of its mammography system, HESTIA, in a national tender in Turkey.

Meanwhile, industry experts anticipate that the domestic and international supply chains secured by GENORAY, along with its partnerships with global companies, will contribute to future revenue growth and improved profitability.